this meeting were the critical evaluation of placental physiology and its development.
This talk gave the participants a deeper understanding about this unique organ of fetal origin. Although multiple attempts have been made to foretell the adverse pregnancy outcomes as a function of placental development, its use as a predictive tool is limited. This is primarily due to its complex location, which prevents biologists for organ/tissue harvest. The placenta mediates the fetal programming.
Over the past decade, increasing numbers of reports have shown that relationships between placental size and shape, modified by maternal phenotypic characteristics, predict chronic diseases in the offspring more powerfully than does the birthweight of baby alone. 1 It would therefore be worthwhile to understand the link between placental development and pregnancy outcome. This may lead to development of new technologies and therapeutic interventions for better management of pregnancy outcomes.
| "-OMICS" APPROACHES
Reports in literature suggest that placental pathology has been associated with various adverse maternal and fetal outcomes like preterm birth, intrauterine growth restriction, and preeclampsia. 2, 3 The mechanisms underlying these pathological pregnancies can be identified and understood better by characterizing the genes important for the normal placental development and function. A powerful approach of doing this is by comparing the differential expression of the genes in normal and pathologic pregnancies. RNA and micro-RNA expression profiles have been studied in preeclamptic placentas as compared to their normotensive counterparts. This has been carried out using different omics approaches like microarray and RNA sequencing with sample size ranging between n=3 and n=21. In most studies, placental tissue has been used as a source of RNA. The genes identified as differentially expressed between the two groups have been validated by qRT PCR. Further, pathway analysis has been performed using different tools such as ingenuity pathway analysis so as to reveal the molecular functions of these genes. These genes have been found to be involved in cellular functions and maintenance, cellular development, cell signaling, lipid metabolism and immunological pathways.
4-10
Similar microarray-based miRNA and RNA expression profiling has been carried out in placental tissue and maternal blood from pregnancies complicated with preterm birth (PTB) and intrauterine growth restriction (IUGR). The differentially expressed genes have been identified to be associated with inflammatory response pathways, cell adhesion mechanisms, vasoregulative pathways and hypoxia-induced pathways.
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| MATERNAL NUTRITION AND PLACENTAL FUNCTION
It is well accepted that maternal nutrition plays a critical role in programming fetal development and growth and also has a profound impact on the future health of the baby. Factors such as the circulating blood in the placenta and umbilical cord, placental barrier thickness, rate of metabolism in the placenta, and placental nutrient transporter expression have been reported to affect the transfer of nutrients from the mother to the growing fetus. 18 Research in this arm of placental function emerged from the early efforts of Barker and colleagues who, in 1986, reported the association between an adverse intrauterine outcome, as determined largely by low birthweight, and an increased risk of coronary heart disease or type 2 diabetes, later in life. These studies were possible because of the birth measurements recorded by hospitals early in the life of subjects who were subsequently examined in mid-and late life.
19-21
These studies gave rise to the now famous "David Barker However, placental shape and size changes with time; hence, with present technology, it is difficult to characterize the fetal outcomes.
Additional factors must now be considered in understanding the placenta as a predictor of adult-onset disease in offspring. These include population nutrition over generations, sex of the baby, maternal nutritional and stress environments, degrees of placental inflammation, and maternal-fetal lipid profiles. Dr. Thornberg's laboratory has identified that the expression of the transporter gene for fats is related to maternal body mass index (BMI) in male fetuses and not in female fetuses. Further, the male fetuses take up free fatty acids from the circulation more readily than the female fetuses. 22 The numerous gaps in our understanding of placental function revealed by these discussions indicate that research is diligently needed to understand the maternalplacental-fetal nutrition axis that is a powerful predictor of disease vulnerability in the offspring at birth and later in adult life.
Prof. C. S. Yajnik, Director from the Diabetes Unit, King Edward
Memorial Hospital, Pune, shared with us the results of the Pune Maternal Nutrition (PMN) Study. This study started in 1991, shadowing the "Developmental Origins of Health and Disease (DOHaD)" approach and the "thin-fat insulin-resistant Indian" concept. Their findings on the role of vitamin B12, folate, and total homocysteine (tHcy) in fetal growth and programming of adiposity leading to insulin resistance have opened a new door in this area. Dr. Yajnik discussed how low maternal vitamin B12 but high folate status predisposes the baby to adiposity and insulin resistance, and risk factors for type 2 diabetes. 23 He also discussed the role of maternal one-carbon (1C) metabolism in fetal growth and programming of diabetes risk through the results obtained in the PMN study. 24 It was re-emphasized that a multidisciplinary approach combining epidemiological findings and molecular biology studies should be pursued together to understand the role of the placenta and its effect in later life of an individual.
| PLACENTAL INFECTION AND INFLAMMATION AND FETAL RESPONSE
Preterm births (PTB) are defined as those births that occur before 37 weeks of gestation. Infection is known to be the leading cause of preterm birth. Various theories have been presented to elucidate the mechanism of intrauterine infection. The most widely accepted theory is that of vertical migration of the microorganisms primarily from the vagina through the cervix, to colonize the fetal membranes, followed by infection/colonization of the amniotic fluid (AF), placenta, and finally the fetus. 25 In addition, it has also been reported that the placenta is hematogenously infected by bacteria residing in the oral cavity that propagate through the maternal bloodstream to the uterine cavity.
26,27
Various conventional techniques such as organism (microbe)-specific PCR, terminal restriction fragment length polymorphism, 16S RNA sequencing and recently introduced techniques like nextgeneration sequencing (NGS) as well as whole-genome sequencing have been used to characterize the total microbiome of the uterine cavity (including placenta). Additionally, NGS methods have been refined to extract the microbial DNA of sufficient purity and quantity for such assays. 28 The increasing interest in NGS-based microbiome research has urged scientists to assess PTB as a polymicrobial disease, because the infectious agents could be bacteria, virus, or fungus such as yeast. the upper part of the myometrium. 36 Endovascular trophoblasts replace the maternal endothelium and acquire a vascular phenotype. 37 These modifications transform high resistance spiral arteries into low resistance spiral arteries thereby facilitating uteroplacental circulation.
38
Failure of endovascular trophoblasts invasion in the placental bed leads to preeclampsia and intrauterine growth restriction (IUGR).
39-42
There are various growth factors secreted by different type of cells at the fetal maternal interface like epidermal growth factor (EGF), vascular endothelial growth factor (vEGF), platelet-derived growth factor (PDGF), placental growth factor (PlGF), colony-stimulating factor-1(CSF-1), insulin growth factor I, IGF-I), or insulin growth factor II (IGF-II).
These have shown to promote proliferation, adhesion, and/or invasion. [43] [44] [45] [46] Apart from the classical growth factors, there are various cytokines and chemokines like CX3CL1, CCL14, CCL4, CXCL16, CCL21, IL-1, IL-6, IL-8, IL-11 and leukemia inhibitory factor (LIF), which are known to promote trophoblast migration and invasion.
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| REAL-TIME EVALUATION OF PLACENTAL DEVELOPMENT: TOOLS FOR PLACENTAL RESEARCH
Abnormal placental structure and function affects the health of the mother as well as the baby. In the mother, abnormal placental function due to structural modifications can cause preeclampsia, gestational hypertension, and eclampsia. [60] [61] [62] [63] This affects the fetus by triggering growth restriction and causing prematurity that could lead to neurodevelopmental abnormalities. 64 There is a gap in our knowledge of the structural development of placenta, because this key organ is available for examination only after the delivery of the baby. Thus, to understand the structure and function of the placenta in real-time, imaging techniques are increasingly becoming the tools of choice over pathological investigations. Conventional 2D ultrasounds have been widely used for evaluating placental morphology, anatomy, location, implantation, anomaly, and size. 65 With the advent of 3D ultrasounds, it has now become possible to measure precise placental volume, 3D placental vasculature, and placental blood flow. 3D ultrasounds provide an improved surface-rendered imaging platform, which essentially helps in providing more detailed information on placental abnormality. Image clarity, resolution, and definition are also presumably better in 3D ultrasounds, as suggested by reports on the prenatal diagnosis of placental abnormalities using 3D surface-rendered imaging.
66,67
Although ultrasounds are still the gold standard for assessing placentas, magnetic resonance imaging (MRI) is also becoming popular.
MRI provides a wider field view to the placenta and better tissue resolution. in utero ultrasound image analysis. She also presented how the correct gestational age (GA) could be predicted by measuring the fetus brain development (head circumference using ultrasound). Further, these measures could be developed as machine-learning algorithms for more accuracy while predicting preterm births. 69 She emphasized that using ultrasound and new predictive tools, one could go beyond what meets the eye to develop non-invasive markers for placental measurements and to access the functionality of this tissue.
Thus, if these ultrasound technologies being used in the present day are studied for their limitations and improved upon, then in vivo imaging could be implemented for real-time assessment of placenta.
Specific morphological features such as its volume, vascularity may be accurately determined by these methods so as to predict adverse pregnancy outcomes.
The discussion forum also presented a platform where young and upcoming researchers were offered the opportunity to share their research and plans toward working in the field of human placenta. The talks of these young investigators are summarized below. 
2.
Profiling of the risk of adverse pregnancy outcomes needs to be further stratified for gender as well as for various sociocultural, socioeconomic, and environmental settings.
3.
Based on the available knowledge of the modifiable factors affecting fetoplacental development, future epidemiological-intervention studies need to be planned in order to improve pregnancy outcomes. These studies should identify effective interventions both during pregnancy and in the pre-conception period.
4.
Systematic banking and archiving of available tissues, including placentae, from such interventional trials are indispensible for the ability to assess the success or failure of the intervention as well as to determine its mechanism of action. Such archiving can either be conducted along with the intervention trial or at least in a retrospective fashion.
| CONCLUSIONS AND GOALS FOR FUTURE RESEARCH
This event witnessed a unique congregation of clinicians and biologists who indulged in clinical and epidemiology-related discussions initiated by the senior participant, with the aim of developing questions on the relevance of placental studies in the Indian context. A successful outcome of these discussions is that public funding bodies like, Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India, have announced and advertised RFAs toward enhancing and promoting science in this area of human placental research. Summarized below are the conclusions from the meeting and action points that need immediate attention to build the framework for this research at a global level.
1.
Consensus on the need for improvement of current methods on human placental development research:
2. Development of non-invasive markers of placental dysfunction for prediction of adverse pregnancy outcome.
3. Development of viable interventions to prevent abnormal placental development.
4.
Use of in vivo imaging as predictive tools: assessment by ultrasound using imaging technology to predict pregnancy outcome.
5.
The non-availability of placental tissues during development across the entire pregnancy period poses technical problems. This severely limits current efforts to understand the mechanism of poor placental function. In particular, currently available tissue is inadequate as the delivered placenta does not cover the junction zone, because the placental bed is left in the uterine wall. To circumvent such problems, it was suggested that resources like maternal blood biopsies could be utilized to study placental insufficiency.
6.
Morphological features of the placenta like the shape, length, breadth and thickness are critical because these are influenced by a number of environmental factors and thereby possibly associated with adverse pregnancy outcome. Non-invasive tools for routine evaluation of these parameters may help in prediction of adverse outcomes.
7.
Biological placental transporters of various nutrients and signaling mechanisms are key areas for further research.
8.
Studies targeting the biological mechanisms of short-and longterm consequences in infants (preterm infants, LBW, IUGR, or infants born to mothers with preeclampsia) need to incorporate sex-specific markers in their study. Robust mechanisms of predicting early and late IUGR would help develop interventional therapies for a healthy later life.
9.
Studies have reported gradients in protein levels, gene expression, and enzyme activities across the normal placenta. Therefore, functional specialization of different regions of the placenta is a potential phenomenon, which requires extensive research.
10.
Epidemiological studies are required to conduct interventions.
Further animal studies are also needed to understand the mechanisms involved.
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